Bristol Myers Squibb EPS beats by $0.08, beats on revenue, boost guidance

seekingalpha2021-10-27

Bristol Myers Squibb(NYSE:BMY): Q3 Non-GAAP EPS of $2.00 beats by $0.08; GAAP EPS of $0.69misses by $0.14. Revenue of $11.62B (+10.2% Y/Y)beats by $100M. Gross margin of 80.3% vs. 81.1% consensus....

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
4